Cyclacel Pharmaceuticals Inc (CYCC)
2.15
+0.32
(+17.49%)
USD |
NASDAQ |
Apr 24, 13:13
Cyclacel Pharmaceuticals Market Cap: 2.834M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 2.412M |
| April 22, 2024 | 2.307M |
| April 19, 2024 | 2.347M |
| April 18, 2024 | 2.439M |
| April 17, 2024 | 2.584M |
| April 16, 2024 | 2.202M |
| April 15, 2024 | 2.070M |
| April 12, 2024 | 2.320M |
| April 11, 2024 | 2.558M |
| April 10, 2024 | 2.702M |
| April 09, 2024 | 2.782M |
| April 08, 2024 | 2.782M |
| April 05, 2024 | 2.768M |
| April 04, 2024 | 2.891M |
| April 03, 2024 | 2.887M |
| April 02, 2024 | 2.795M |
| April 01, 2024 | 2.702M |
| March 28, 2024 | 2.782M |
| March 27, 2024 | 2.584M |
| March 26, 2024 | 2.531M |
| March 25, 2024 | 2.821M |
| March 22, 2024 | 2.884M |
| March 21, 2024 | 2.874M |
| March 20, 2024 | 2.966M |
| March 19, 2024 | 3.098M |
| Date | Value |
|---|---|
| March 18, 2024 | 3.309M |
| March 15, 2024 | 3.204M |
| March 14, 2024 | 3.290M |
| March 13, 2024 | 3.414M |
| March 12, 2024 | 3.271M |
| March 11, 2024 | 3.322M |
| March 08, 2024 | 3.480M |
| March 07, 2024 | 3.283M |
| March 06, 2024 | 3.124M |
| March 05, 2024 | 3.414M |
| March 04, 2024 | 3.559M |
| March 01, 2024 | 3.823M |
| February 29, 2024 | 3.375M |
| February 28, 2024 | 3.533M |
| February 27, 2024 | 3.586M |
| February 26, 2024 | 3.691M |
| February 23, 2024 | 3.494M |
| February 22, 2024 | 3.467M |
| February 21, 2024 | 3.579M |
| February 20, 2024 | 3.863M |
| February 16, 2024 | 3.914M |
| February 15, 2024 | 3.513M |
| February 14, 2024 | 3.389M |
| February 13, 2024 | 3.283M |
| February 12, 2024 | 3.243M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.070M
Minimum
Apr 15 2024
77.03M
Maximum
Mar 19 2021
20.94M
Average
13.12M
Median
Market Cap Benchmarks
| Corvus Pharmaceuticals Inc | 74.54M |
| Oragenics Inc | 4.929M |
| Relmada Therapeutics Inc | 116.93M |
| Alpine Immune Sciences Inc | 4.234B |
| MAIA Biotechnology Inc | 52.38M |
Market Cap Related Metrics
| Price to Book Value | 4.669 |
| Price | 2.15 |
| Earnings Yield | -1.24K% |